ArticleNature and science of sleep2025
Exploring the Arousal Intensity in Patients with Obstructive Sleep Apnea: Based on Odds Ratio Product.
Article in Nature and science of sleep, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aim: Obstructive sleep apnea (OSA) is characterized by repetitive upper airway collapse during sleep, resulting in frequent cortical arousals. However, currently used frequency-based arousal metrics do not sufficiently capture the heterogeneity and clinical significance of arousal responses. The odds ratio product (ORP) is a novel electroencephalographic marker that provides a continuous assessment of sleep depth and has the potential to serve as an objective measure of arousal intensity. Purpose: This study aimed to quantify the intensity of arousals in untreated OSA patients using the ORP, and to explore the relationships between arousal intensity, respiratory event features, and subjective sleepiness. Patients and Methods: We retrospectively analysed data from 1057 adults with untreated OSA enrolled in the APPLES cohort. EEG spectral power was mapped to ORP values, and arousal intensity for each event was objectively calculated based on deviations in ORP from baseline. A total of 258,121 arousal events were included. Mixed-effects modelling was used to assess the impact of event type, duration, latency, sleep stage, position, and inter-individual variability on arousal intensity. Stepwise multiple regression explored associations between individual arousal intensity and subjective sleepiness. Results: Arousal intensity increased significantly with the duration of preceding respiratory events, and was markedly higher than that of spontaneous arousals. The association between respiratory events and arousal intensity was stronger for apneas than for hypopneas, while deep sleep stage and lateral posture significantly reduced arousal response. Inter-individual variability was pronounced. Higher baseline arousal intensity was independently associated with increased subjective daytime sleepiness, after adjusting for known confounders. Conclusion: ORP-derived arousal intensity provides a quantitative biomarker of cortical arousal. Arousal intensity is shaped by respiratory event characteristics, sleep architecture, and intrinsic individual traits. Although slight, arousal intensity is independently associated with subjective daytime sleepiness.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.